Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results.
Bridgeline Digital posted a narrower-than-expected loss for its fourth quarter, while sales missed estimates.
Issues New Warrants to this Investment Group for Possible Additional Funding of Up to $3.47 Million (if exercised)
Cyclo Therapeutics, Inc. (NASDAQ:CYTH) ("Cyclo Therapeutics" or the